AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?
Choosing between a high-yield pharmaceutical powerhouse and a diversified healthcare leader requires looking at growth and stability. You…
Why US multinationals keep choosing Ireland. It’s not just the tax or workforce – The Irish Times
If you ask US multinationals why they choose Ireland as a base for investment, they’ll talk about the…
SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease
SKYRIZI (risankizumab-rzaa) is now approved for patients six years of age and older with moderate-to-severe plaque psoriasis or…
64 Years Old With $1.1 Million in a Traditional IRA. Here’s Where I’m Allocating Capital
Quick Read KO and ABBV anchor the portfolio at 25% each, rated Very Safe with payout ratios under…
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Investors seeking reliable dividends and healthcare exposure often find themselves choosing between AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE). Both…
2 High-Yield Healthcare Stocks to Buy Before They Raise Payouts
It’s safe to say the healthcare sector isn’t renowned as a repository of dividend-paying companies. Yet some not…
Humira’s TrumpRx Discount Raises New Questions For AbbVie Valuation
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
Best Healthcare Stocks to Buy After the Market Pullback
Equity markets have moved in the wrong direction over the past three weeks. They may not rebound and…
If You Have $500,000 Saved at 60, Here’s The Sort of Monthly Income You Can Count On
Verizon (VZ) yields 5.4% at its current price, paying $0.69 per quarter and offering higher current income for…
Buying This Healthcare Stock Could Make You a Millionaire Retiree
AbbVie has a solid business capable of performing well even in bad times. The company has proven that…
1 Major Factor Behind the Healthcare Sector’s Recent Surge
Eli Lilly’s GLP-1 drug became the world’s best-selling drug in Q3. Merck, Johnson & Johnson, AbbVie, and other…
Deal With Eli Lilly Propels Founder Of Korean Biotech Firm Into Billionaire Ranks
A $2.6 billion licensing and joint research deal with Eli Lilly boosted shares of South Korean biotech company…